Corn snack study: whole grain may tame blood sugar spikes
NCT ID NCT07427654
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested how three corn snacks with different amounts of whole grain affect blood sugar in 29 healthy adults. Participants ate the snacks and a sugar drink on separate days, and researchers measured their blood sugar responses. The goal was to see if more whole grain leads to a lower glycemic index, which could help people make smarter snack choices.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Corn snacks with varying whole-grain levels and a dextrose control drink
- What this could lead to
- If successful, this could help identify which corn-based foods have a lower glycemic index, guiding healthier snack choices.
- What could go wrong
- This is a small, completed study in healthy adults, so results may not apply to people with diabetes or other conditions. The sponsor is PepsiCo, which may introduce bias.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
29 people
The number who actually took part.
- Started
-
Jan 2026
- Finished
-
Mar 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-75 years, inclusive. * BMI between 18.0 and 35.0 Kg/m2. * Willing to abstain from unusual strenuous exercise and consuming alcoholic drinks for 24 hours before study days. * Willing to refrain from smoking tobacco or marijuana for 12h before and during study visits. * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial. * Understanding the study procedures \& willing to provide informed consent to participate in the study \& authorization to release relevant protected health information to the study investigator. * Participants must be eligible to receive income in Canada and be covered by a health insurance plan such as OHIP. Exclusion Criteria: * Self-reported pregnant or breastfeeding women. * Known history of gastrointestinal disease (e.g., diverticulitis, Crohns disease, coeliac disease etc.), bariatric surgery, AIDS, hepatitis, a history or presence of clinically important endocrine (including Type 1 or Type 2 diabetes mellitus), or any condition which might, in the opinion of the medical director either: 1) make participation dangerous to the participant or to others, or 2) affect the results. * Use of medications known to influence carbohydrate metabolism, gastrointestinal function or appetite, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of the screening visit, or any medication which might, in the opinion of the medical director either: 1) make participation dangerous to the participant or to others, or 2) affect the results. * Major trauma or surgical event within 3 months of screening. * Unwillingness or inability to comply with the experimental procedures and to follow INQUIS health and safety policies. * Known intolerance, sensitivity or allergy to test products. * Participation in any clinical trial within the past 30 days (with the exception of routine GI testing of commonly consumed foods) or any PepsiCo sponsored trial within the past 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Glycemic index are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
INQUIS Clinical Research
Toronto, Ontario, M5C 2N8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.